ARCHIVES

Atrix, Sanofi In Marketing Deal For Leuprogel Products.

This article is from The Cancer Letter archive.

Vol. 27 No. 04 | January 26, 2001

Download PDF Visit The Full Archive

Related Articles

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

November 9, 2001

Waxman To Speak At AACI Meeting

January 12, 1979

Calcitrol+Docetaxel Prolongs Survival In Prostate Cancer

June 24, 2005

Survival Rates Same For Two Treatments For Eye Cancer: Radiation Or Removal

July 27, 2001

St. Jude Children’s Research Hospital Wins NCI Designation As Comprehensive.

May 16, 2008

Q&A: Data that Killed CYP2D6 Testing Contradict Fundamental Law of Nature

May 18, 2012